• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

采用超灵敏非提取游离脂肪酸定量法监测治疗性蛋白中聚山梨酯的水解。

Monitoring polysorbate hydrolysis in therapeutic proteins using an ultrasensitive extraction-free fatty acid quantitation method.

机构信息

Analytical Chemistry, Regeneron Pharmaceuticals, Tarrytown, NY, 10591, USA.

Formulation Group, Regeneron Pharmaceuticals, Tarrytown, NY, 10591, USA.

出版信息

Anal Biochem. 2022 Jan 15;637:114472. doi: 10.1016/j.ab.2021.114472. Epub 2021 Nov 18.

DOI:10.1016/j.ab.2021.114472
PMID:34801481
Abstract

Polysorbates (PSs) are surfactants commonly added to therapeutic protein drug product formulations to protect proteins from denaturation and aggregation during storage, transportation, and delivery. However, enzymatic hydrolysis of PSs has been recognized as the primary route of PS degradation in monoclonal antibody formulations, resulting in the release of free fatty acids that drive undesired particulate formation. Here, we present a rapid lipase activity assay with optimized incubation conditions for accurate quantitation of free fatty acids without a fatty acid extraction step. This assay can detect low levels of PS degradation (0.000024% PS20 degradation) within 1 day with minimal sample preparation. The levels of released free fatty acids were found to strongly correlate with the degree of PS20 degradation. The case study described herein suggests that this approach can detect low levels of PS20 degradation caused by sub-ppm lipase levels within 1 day, compared with the duration of 14 days needed for PS degradation assays based on two-dimensional liquid chromatography-charge aerosol detection.

摘要

聚山梨酯(PS)是一种常用的表面活性剂,添加到治疗性蛋白药物产品配方中,以保护蛋白质在储存、运输和给药过程中免于变性和聚集。然而,酶水解聚山梨酯已被认为是单克隆抗体配方中聚山梨酯降解的主要途径,导致释放游离脂肪酸,从而驱动不希望的颗粒形成。在这里,我们提出了一种快速的脂肪酶活性测定方法,优化了孵育条件,可在无需脂肪酸提取步骤的情况下准确定量游离脂肪酸。该测定法可在 1 天内检测到低水平的 PS 降解(PS20 降解 0.000024%),样品制备量最少。结果表明,释放的游离脂肪酸水平与 PS20 降解程度密切相关。本文所述的案例研究表明,与基于二维液相色谱-荷质比检测的 PS 降解测定法需要 14 天相比,该方法可在 1 天内检测到由亚ppm 级脂肪酶水平引起的 PS20 低水平降解。

相似文献

1
Monitoring polysorbate hydrolysis in therapeutic proteins using an ultrasensitive extraction-free fatty acid quantitation method.采用超灵敏非提取游离脂肪酸定量法监测治疗性蛋白中聚山梨酯的水解。
Anal Biochem. 2022 Jan 15;637:114472. doi: 10.1016/j.ab.2021.114472. Epub 2021 Nov 18.
2
A Rapid High-Sensitivity Reversed-Phase Ultra High Performance Liquid Chromatography Mass Spectrometry Method for Assessing Polysorbate 20 Degradation in Protein Therapeutics.一种快速高灵敏度反相超高效液相色谱质谱法评估蛋白质治疗药物中聚山梨酯 20 降解。
J Pharm Sci. 2019 Sep;108(9):2880-2886. doi: 10.1016/j.xphs.2019.04.029. Epub 2019 May 2.
3
Stress-mediated polysorbate 20 degradation and its potential impact on therapeutic proteins.应激介导的聚山梨酯 20 降解及其对治疗性蛋白的潜在影响。
Pharm Res. 2024 Jun;41(6):1217-1232. doi: 10.1007/s11095-024-03700-7. Epub 2024 May 13.
4
Improving Prediction of Free Fatty Acid Particle Formation in Biopharmaceutical Drug Products: Incorporating Ester Distribution during Polysorbate 20 Degradation.提高生物制药制剂中游离脂肪酸粒子形成预测的准确性:在聚山梨酯 20 降解过程中考虑酯分布。
Mol Pharm. 2020 Nov 2;17(11):4354-4363. doi: 10.1021/acs.molpharmaceut.0c00794. Epub 2020 Oct 8.
5
Polysorbate 20 Degradation in Biopharmaceutical Formulations: Quantification of Free Fatty Acids, Characterization of Particulates, and Insights into the Degradation Mechanism.生物制药制剂中聚山梨醇酯20的降解:游离脂肪酸的定量、颗粒的表征及降解机制的深入研究
Mol Pharm. 2015 Nov 2;12(11):3805-15. doi: 10.1021/acs.molpharmaceut.5b00311. Epub 2015 Oct 13.
6
Assessing the polysorbate degradation fingerprints and kinetics of lipases - how the activity of polysorbate degrading hydrolases is influenced by the assay and assay conditions.评估聚山梨酯降解指纹和脂肪酶动力学——聚山梨酯降解水解酶的活性如何受测定和测定条件的影响。
Eur J Pharm Sci. 2021 Nov 1;166:105980. doi: 10.1016/j.ejps.2021.105980. Epub 2021 Aug 20.
7
Characterization of Polysorbate Ester Fractions and Implications in Protein Drug Product Stability.聚山梨酯酯级分的特性及其对蛋白药物产品稳定性的影响。
Mol Pharm. 2020 Jul 6;17(7):2345-2353. doi: 10.1021/acs.molpharmaceut.0c00093. Epub 2020 Jun 5.
8
All-in-one stability indicating polysorbate 20 degradation root-cause analytics via UPLC-QDa.基于 UPLC-QDa 的单一组分稳定性指示聚山梨酯 20 降解根本原因分析。
J Chromatogr B Analyt Technol Biomed Life Sci. 2024 Jan 1;1232:123955. doi: 10.1016/j.jchromb.2023.123955. Epub 2023 Dec 7.
9
Understanding Particle Formation: Solubility of Free Fatty Acids as Polysorbate 20 Degradation Byproducts in Therapeutic Monoclonal Antibody Formulations.理解颗粒形成:游离脂肪酸作为聚山梨酯20降解副产物在治疗性单克隆抗体制剂中的溶解度
Mol Pharm. 2015 Nov 2;12(11):3792-804. doi: 10.1021/acs.molpharmaceut.5b00310. Epub 2015 Oct 13.
10
Degradation of Polysorbate 20 by Sialate O-Acetylesterase in Monoclonal Antibody Formulations.单克隆抗体制剂中唾液酸O-乙酰酯酶对聚山梨酯20的降解作用
J Pharm Sci. 2021 Dec;110(12):3866-3873. doi: 10.1016/j.xphs.2021.09.001. Epub 2021 Sep 4.

引用本文的文献

1
Stress-mediated polysorbate 20 degradation and its potential impact on therapeutic proteins.应激介导的聚山梨酯 20 降解及其对治疗性蛋白的潜在影响。
Pharm Res. 2024 Jun;41(6):1217-1232. doi: 10.1007/s11095-024-03700-7. Epub 2024 May 13.
2
Prediction of long-term polysorbate degradation according to short-term degradation kinetics.根据短期降解动力学预测聚山梨酯的长期降解情况。
MAbs. 2023 Jan-Dec;15(1):2232486. doi: 10.1080/19420862.2023.2232486.
3
The measurement and control of high-risk host cell proteins for polysorbate degradation in biologics formulation.
生物制品制剂中聚山梨酯降解的高风险宿主细胞蛋白的测量与控制。
Antib Ther. 2022 Jan 15;5(1):42-54. doi: 10.1093/abt/tbac002. eCollection 2022 Jan.